The pathophysiology of acute heart failure-It is a lot about fluid accumulation

American Heart Journal

Volumn 155, Issue 1, 2008, Pages 1-5

  Metra, Marco ^a   Dei Cas, Livio ^a   Bristow, Michael R ^b  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FUROSEMIDE; TOLVAPTAN;

ACUTE HEART FAILURE; CARDIOVASCULAR PARAMETERS; CORONARY VASCULAR RESISTANCE; EDITORIAL; HOSPITALIZATION; HUMAN; LUNG FLUID; MORTALITY; PATHOGENESIS; PATHOPHYSIOLOGY; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; SYMPTOMATOLOGY;

ACUTE DISEASE; AGE FACTORS; AGED; AGED, 80 AND OVER; EDEMA, CARDIAC; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; MALE; PROGNOSIS; RISK ASSESSMENT; SURVIVAL ANALYSIS; VASCULAR RESISTANCE;

EID: 36849050906     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.10.011     Document Type: Editorial

References (47)

1. McMurray J., McDonagh T., Morrison C.E., et al. Trends in hospitalisation for heart failure in Scotland 1980-1990. Eur Heart J 14 (1993) 1158-1162
2. O'Connell J.B., and Bristow M.R. Economic impact of heart failure in the United States: time for a different approach. J Heart Lung Transplant 13 (1994) S107-S112
3. Adams Jr. K.F., Fonarow G.C., Emerman C.L., et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 149 (2005) 209-216
4. Gheorghiade M., Abraham W.T., Albert N.M., et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA 296 (2006) 2217-2226
5. Nieminen M.S., Brutsaert D., Dickstein K., et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J 27 (2006) 2725-2736
6. Tavazzi L., Maggioni A.P., Lucci D., et al. Nationwide survey on acute heart failure in cardiology ward services in Italy. Eur Heart J 27 (2006) 1207
7. Rudiger A., Harjola V.-P., Muller A., et al. Acute heart failure: clinical presentation, one-year mortality and prognostic factors. Eur J Heart Fail 7 (2005) 662-670
8. Lee D.S., Austin P.C., Rouleau J.L., et al. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA 290 (2003) 2581-2587
9. Cleland J.G., Swedberg K., Follath F., et al. The EuroHeart Failure survey programme-a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 24 (2003) 442-463
10. O'Connor C.M., Stough W.G., Gallup D.S., et al. Demographics, clinical characteristics, and outcomes of patients hospitalized for decompensated heart failure: observations from the IMPACT-HF registry. J Card Fail 11 (2005) 200-205
11. Schaufelberger M., Swedberg K., Koster M., et al. Decreasing one-year mortality and hospitalisation rates for heart failure in Sweden; data from the Swedish Hospital Discharge Registry 1988 to 2000. Eur Heart J 25 (2004) 300-307
12. Cotter G., Felker G.M., Adams K.F., et al. The pathophysiology of acute heart failure-is it all about fluid accumulation?. Am Heart J 155 (2008) 9-18
13. Cotter G., Moshkovitz Y., Milovanov O., et al. Acute heart failure: a novel approach to its pathogenesis and treatment. Eur J Heart Fail 4 (2002) 227-234
14. Nieminen M.S., Bohm M., Cowie M.R., et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 26 (2005) 384-416
15. Gheorghiade M., Zannad F., Sopko G., et al. Acute heart failure syndromes: current state and framework for future research. Circulation 112 (2005) 3958-3968
16. Cotter G., Metzkor E., Kaluski E., et al. Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. Lancet 351 (1998) 389-393
17. Fonarow G.C., Adams Jr. K.F., Abraham W.T., et al. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA 293 (2005) 572-580
18. Goldberg R.J., Spencer F.A., Farmer C., et al. Incidence and hospital deaths rates associated with heart failure: a community-wide perspective. Am J Med 118 (2005) 728-734
19. Zannad F., Mebazaa A., Juilliére Y., et al. Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: the EFICA study. Eur J Heart Fail 8 (2006) 697-705
20. Abraham W.T., and Bristow M.R. Specialized centers for heart failure management. Circulation 96 (1997) 2755-2757
21. McAlister F.A., Stewart S., Ferrua S., et al. Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials. J Am Coll Cardiol 44 (2004) 810-819
22. Yu C.M., Wang L., Chau E., et al. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation 112 (2005) 841-848
23. Packer M., Abraham W.T., Mehra M.R., et al. Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failure. J Am Coll Cardiol 47 (2006) 2245-2252
24. Adamson P.B., Magalski A., Braunschweig F., et al. Ongoing right ventricular hemodynamics in heart failure: clinical value of measurements derived from an implantable monitoring system. J Am Coll Cardiol 41 (2003) 565-571
25. Cleland J.G., Coletta A.P., Freemantle N., et al. Clinical trials update from the American College of Cardiology meeting: CARE-HF and the remission of heart failure, Women's Health Study, TNT, COMPASS-HF, VERITAS, CANPAP, PEECH and PREMIER. Eur J Heart Fail 7 (2005) 931-936
26. Richards M., and Troughton R.W. NT-proBNP in heart failure: therapy decisions and monitoring. Eur J Heart Fail 6 (2004) 351-354
27. Stevenson L.W., and Perloff J.K. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA 261 (1989) 884-888
28. Stevenson L.W., Dracup K.A., and Tillisch J.H. Efficacy of medical therapy tailored for severe congestive heart failure in patients transferred for urgent cardiac transplantation. Am J Cardiol 63 (1989) 461-464
29. O'Brien R.J., Squire I.B., Demme B., et al. Pre-discharge, but not admission, levels of NT-proBNP predict adverse prognosis following acute LVF. Eur J Heart Fail 5 (2003) 499-506
30. Pozzoli M., Traversi E., Cioffi G., et al. Loading manipulations improve the prognostic value of Doppler evaluation of mitral flow in patients with chronic heart failure. Circulation 95 (1997) 1222-1230
31. Drazner M.H., Rame J.E., Stevenson L.W., et al. Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med 345 (2001) 574-581
32. Lucas C., Johnson W., Hamilton M.A., et al. Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure. Am Heart J 140 (2000) 840-847
33. Gheorghiade M., Filippatos G., DeLuca L., and Burnett J. Congestion in acute heart failure syndromes: an essential target of evaluation and treatment. Am J Med 119 12 Suppl 1 (2006) S3-S10
34. Rogers J.G., Helkamp A.S., Young J.B., et al. Low congestion score one month after hospitalization predicts better function and survival. J Am Coll Cardiol 49 Suppl A (2007) 47A [abstract]
35. Mann D.L., and Bristow M.R. Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation 111 (2005) 2837-2849
36. Agostoni P.G., Marenzi G.C., Pepi M., et al. Isolated ultrafiltration in moderate congestive heart failure. J Am Coll Cardiol 21 (1993) 424-431
37. Chomsky D.B., Lang C.C., Rayos G., et al. Treatment of subclinical fluid retention in patients with symptomatic heart failure: effect on exercise performance. J Heart Lung Transplant 16 (1997) 846-853
38. Domanski M., Norman J., Pitt B., et al. Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 42 (2003) 705-708
39. Domanski M., Tian X., Haigney M., et al. Diuretic use, progressive heart failure, and death in patients in the DIG study. J Card Fail 12 (2006) 327-332
40. Ahmed A., Husain A., Love T.E., et al. Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods. Eur Heart J 27 (2006) 1431-1439
41. Leier C.V., DeiCas L., and Metra M. Clinical relevance and management of the major electrolyte abnormalities in congestive heart failure: hyponatremia, hypokalemia, and hypomagnesemia. Am Heart J 128 (1994) 564-574
42. Francis G.S., Benedict C., Johnstone D.E., et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 82 (1990) 1724-1729
43. Weber K.T. Furosemide in the long-term management of heart failure: the good, the bad, and the uncertain. J Am Coll Cardiol 44 (2004) 1308-1310
44. Marenzi G., Grazi S., Giraldi F., et al. Interrelation of humoral factors, hemodynamics, and fluid and salt metabolism in congestive heart failure: effects of extracorporeal ultrafiltration. Am J Med 94 (1993) 49-56
45. Costanzo M.R., Guglin M.E., Saltzberg M.T., et al. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 49 (2007) 675-683
46. Gheorghiade M., Konstam M.A., Burnett Jr. J.C., et al. Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST clinical status trials. JAMA 297 (2007) 1332-1343
47. Konstam M.A., Gheorghiade M., Burnett Jr. J.C., et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST outcome trial. JAMA 297 (2007) 1319-1331